$12.690
-0.039 (-0.31%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
NTLA 相似图表分析预测
Alphio's NTLA stock price prediction model matches the current Intellia Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.79 (+0.85%). The 1-week path is $12.96 (+2.13%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Intellia Therapeutics Inc 股票吗？
Intellia Therapeutics Inc is currently priced at $12.87, which is below the average analyst price target of $17, indicating potential upside. However, the company has a negative net income of -106634000 USD in Q2 2026 and a concerning insider selling increase of 2235.78%, which raises risks for investors. Given these mixed signals, it's prudent to hold rather than buy at this time.
NTLA 股价于 Tuesday 收于 $12.69，此前下跌 -0.31%
Intellia Therapeutics Inc (NTLA) last closed at $12.685, losing -0.35%. These facts feed the 1-day and 1-week NTLA price prediction above.
分析师一致预期
Intellia Therapeutics Inc（NTLA）：买入 4、持有 2、卖出 0。展望：Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
预测驱动因素
Intellia Therapeutics Inc（NTLA）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
相似图表形态
近期走势与 NTLA 最接近的股票，按相似度排序。
NTLA 季节性分析
Historically the probability of a positive September return for NTLA is 28.57%. October offers the highest probability of a positive month at 50.00%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。